Based on an estimated 4-8 hour half-life, 5-Amino-1MQ would be virtually gone from the body within about 20 to 40 hours after the final dose
Roche believes that combining an amylin analogue can help distribute the appetite-suppressing effect more gradually compared to GLP-1 monotherapy, while also reducing the intensity of gastrointestinal side effects such as nausea
No evidence of cardiac, hepatic, or renal toxicity, changes in serum lipids, or clinically relevant changes in laboratory parameters, vital signs, electrocardiograms, or abnormal findings upon physical examinations have been observed
Athletes & Active Lifestyles You train hard and recover smart
For reference, I am 57 tall and weigh ~130 lbs
The SURMOUNT-4 trial showed that 82.5% of participants who stopped tirzepatide regained at least 25% of their lost weight within one year